UC AKT.ANL. 06/25 OMV/ DE000HD9LTM0 /
22/11/2024 11:46:08 | Chg.- | Bid13:14:08 | Demandez à22/11/2024 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
100.310EUR | - | 100.210 Bid taille: 400,000 |
- Ask la taille: 400,000 |
OMV AG | 36.00 - | 27/06/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
- La première page
- Retour
- 1
- 2
- Suivant
- La dernière page